Continuous glucose monitors are small, wearable devices that track blood sugar levels in real-time. While the devices are commonly prescribed to diabetics to titrate medications (e.g. insulin) to ...

Continuous glucose monitoring (CGM) devices provide real-time blood sugar readings 24 hours a day, allowing people with type 1 or type 2 diabetes to closely track blood glucose levels and trends. Most ...

CNET’s expert staff reviews and rates dozens of new products and services each month, building on more than a quarter century of expertise.

Abbott and Dexcom settled all patent lawsuits related to continuous glucose monitors (CGMs ... In March 2024, a jury found that Dexcom’s G6 glucose monitors infringed one of three of Abbott’s patents, ...

Abbott and Dexcom settled all patent lawsuits related to continuous glucose monitors ... In March 2024, a jury found that Dexcom’s G6 glucose monitors infringed one of three of Abbott’s ...

Notably, Dexcom continues to innovate, with a future iteration of its CGM on the way. Sayer described the next-generation ...

(Nasdaq: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, today announced the Dexcom G6 Continuous Glucose Monitoring (CGM) System is being worn by ...

Latin America continuous glucose monitoring device market is estimated to be valued at US$ 219.3 mn in 2025 and is expected to exhibit a CAGR of 15.8% by 2032 BURLINGAME, CA, UNITED STATES ...

DexCom, Inc. DXCM is well-poised for growth in the coming quarters, backed by its strong product portfolio. A better-than-expected third-quarter 2024 performance and a series of favorable coverage ...

Comprehensive Analysis of the US Market Size and Growth Rate for Continuous ... landscape. Dexcom is a prominent player in the CGM market, known for its innovative glucose monitoring systems.